IAMBIC
Better technology for better medicines
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2024
- Business Model
- B2B
- Website
- iambic.co
- Total Funding
- $1.5M
About
Iambic Therapeutics is a clinical-stage AI-driven biotech company headquartered in La Jolla, California. Founded in 2019, Iambic has built a cutting-edge platform combining multimodal transformer AI (Enchant) and co-folding technology (NeuralPLexer) to tackle the most challenging problems in drug discovery. The platform enables high-throughput experimental cycles that convert novel molecular designs into biological insights each week, delivering differentiated clinical candidates years faster than industry standard. Iambic's pipeline includes programs targeting HER2, KIF18A, and CDK2/4 for various cancers. The company has announced strategic collaborations with Takeda and Lundbeck.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account